The Mark Foundation for Cancer Research

“The Mark Foundation is different from other organizations. All types of cancer are in scope for us, and that was by design, from the beginning.”—Ryan Schoenfeld, CEO Watch our new video to learn how we are accelerating progress in the fight against cancer. vimeo.com/1013135446

How do you create a drug for a protein with no fixed shape? In @ScienceAdvances, ASPIRE Awardees Xavier Salvatella (@xsalvatella1) and Denes Hnisz (@dhnisz) show that intrinsically disordered proteins can be successfully targeted during oligomerization. science.org/doi/10.1126/sc…

Thank you @TheMarkFdn for the kind words and for the support. Thrilled to join the physician scientist community at @the_asci

🌟Our Emerging Leader Award winners are superstars - and two of them were just elected to @the_asci! Congratulations, @MarioSuva and @Samuel_Bakhoum! 🚀 the-asci.org/controllers/as…

Supporting science at the intersection of aging biology + cancer, @TheMarkFdn @WaxmanCancer announced $2.5M to take aim at the leading risk factor for cancer: aging. This initiative brings together a multi-org partnership including @AmericanCancer and CRI: bit.ly/3ZpVvD8

Learn more about the Aging & Cancer awards and our mission to reshape how cancer is prevented and treated as we age on the new Waxman Institute website: 🔗 waxmaninstitute.org and themarkfoundation.org/waxmaninstitut…

Omer Yilmaz (@ohyilmaz) of @MIT and Andrew Chan of @MassGeneralNews are studying how the aging gut’s "stem cell niche" breaks down and testing whether low-dose aspirin can restore a healthier environment to prevent colorectal cancer. 💊

📢 Announcing $2.5 million for Aging & Cancer research! 📢 In partnership with @WaxmanCancer, @AmericanCancer, and @CancerResearch, we are funding 5 collaborative teams to tackle the #1 risk factor for cancer: aging. 🧬⏳ themarkfoundation.org/2026/03/multi-…

Yesterday, The Mark Foundation's @Becky_ABC visited @CRUK_SI in Glasgow, where she met with institute director & MFCR grantee Owen Samson and his colleagues. Great to see their work in action! 🏴󠁧󠁢󠁳󠁣󠁴󠁿

Congratulations to I3H member Nikolaos Sgourakis (University of Pennsylvania & Children’s Hospital of Philadelphia) on new funding from the @TheMarkFdn and a new coalition of leading nonprofits dedicated to advancing early cancer detection. Learn more: bit.ly/3MVytRW

Congratulations to all of the new teams! 🎉

Live from the @CancerGrand Challenges Summit in London! 🇬🇧 Mark Foundation Board Chair @Rndubois just shared his vision for the next 10 years of cancer research on an incredible panel. The future of discovery is bright. 🧬🌟

Congratulations to SCI members @corsellos and Nathanael Gray on receiving @TheMarkFdn’s 2026 #DrugDiscovery Award for their project, "TRIM21 E3 Ligase Reprogramming for Cancer Therapy." brnw.ch/21x0qp4 #PancreaticCancer

"To turn an academic discovery into a therapeutic reality, researchers need more than funding." — CEO Ryan Schoenfeld Learn how we provide industry mentorship and CRO guidance to move these projects toward the clinic: 🔗themarkfoundation.org/2026/03/the-ma…

@Eric_fischer and Scott Armstrong (@Armstrong_dfci) at @DanaFarberNews are targeting the proteins fueling leukemia and lung cancer by developing a novel "molecular glue" to degrade faulty gene expressions. 🧪✨

📢 We are proud to announce 4 new Drug Discovery Award recipients! 📢 Our Drug Discovery Awards provide $1M per team + industry-level rigor to help academic researchers transform their lab findings into high-potential cancer therapeutics. 🔬🧪💊 themarkfoundation.org/2026/03/the-ma…